Obesity News

New data show that the number of youths with diabetes may increase from 185,000 with type 1 diabetes and 28,000 with type 2 diabetes in 2017 to 191,000 with type 1 diabetes and 48,000 with type 2 diabetes by 2060 if current trends continue.

The AAP on Monday released its first clinical guidance on obesity in 15 years, suggesting that physicians offer adolescents as young as age 12 years weight loss medication and evaluate teens for metabolic and bariatric surgery.

In a recent study, researchers found that adults with prediabetes who wore a flash glucose monitoring sensor reported high satisfaction and said it influenced them to make positive behavior changes based on their glucose levels.

The FDA approved once-weekly semaglutide for the treatment of obesity among adolescents aged 12 to 17 years with an initial BMI in the 95th percentile for age and sex, according to a press release.

With a lack of well-defined guidelines, many primary care providers in the United Kingdom provided generic weight-loss advice to patients with obesity, a recent study found.

A calorie-restricted intermittent fasting intervention demonstrated clinical efficacy in achieving type 2 diabetes remission, a recent study showed.

The CDC released extended charts so clinicians can assess the growth and treatment of children and adolescents with severe obesity.

Obesity was not a universal phenotype among children with type 2 diabetes, despite being an important risk factor, according to a systematic review and meta-analysis published in JAMA Network Open.

A recent study found that patients with type 2 diabetes who used a GLP-1 receptor agonist for more than 1 year had an increased risk for thyroid cancer compared with non-users.

Primary care provider referral to an automated weight-loss program resulted in significantly increased weight loss at 6 and 12 months vs. usual care, according to study findings published in Obesity.